Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016

MacNeil, Jessica R.; Rubin, Lorry G.; Patton, Monica E.; Ortega-Sánchez, Ismael R.; Martin, Stacey W.

doi:10.15585/mmwr.mm6543a3

Cited by 67 publications

(48 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our findings are consistent with those of other population-based studies that have shown an increased incidence of meningococcal disease among HIV-infected persons [11–13]. Considering these studies, in June 2016 the US Advisory Committee on Immunization Practices approved a recommendation for routine vaccination of HIV-infected persons aged ≥2 months [26]. …”

Section: Discussionsupporting

confidence: 91%

Meningococcal Disease in Patients With Human Immunodeficiency Virus Infection: A Review of Cases Reported Through Active Surveillance in the United States, 2000–2008

Harris

et al. 2016

Open Forum Infectious Diseases

Self Cite

View full text Add to dashboard Cite

Background.Although human immunodeficiency virus (HIV) infection is an established risk factor for several bacterial infections, the association between HIV infection and meningococcal disease remains unclear.Methods.Expanded chart reviews were completed on persons with meningococcal disease and HIV infection reported from 2000 through 2008 from 9 US sites participating in an active population-based surveillance system for meningococcal disease. The incidence of meningococcal disease among patients meeting Centers for Disease Control and Prevention acquired immune deficiency syndrome (AIDS) surveillance criteria was estimated using data from the National HIV Surveillance System for the participating sites.Results.Thirty-three cases of meningococcal disease in individuals with HIV infection were reported from participating sites, representing 2.0% of all reported meningococcal disease cases. Most (75.8%) persons with HIV infection were adult males aged 25 to 64 years old. Among all meningococcal disease cases aged 25 to 64 years old, case fatality ratios were similar among HIV-infected and HIV-uninfected persons (13.3% vs 10.6%; P = .6). The cumulative, mean incidence of meningococcal disease among patients aged 25 to 64 years old with HIV infection ever classified as AIDS was 3.5 cases per 100000 person years (95% confidence interval [CI], 2.1–5.6), compared with 0.3 cases per 100000 person years (95% CI, 0.3–0.3) for persons of the same age group not reported to have AIDS (relative risk = 12.9; 95% CI, 7.9–20.9).Conclusions.Individuals with HIV infection meeting the AIDS surveillance case definition have a higher incidence of meningococcal disease compared with the general adult population.

show abstract

Section: Discussionsupporting

confidence: 91%

Meningococcal Disease in Patients With Human Immunodeficiency Virus Infection: A Review of Cases Reported Through Active Surveillance in the United States, 2000–2008

Harris

et al. 2016

Open Forum Infectious Diseases

Self Cite

View full text Add to dashboard Cite

show abstract

“…68 Individuals with HIV who have been previously vaccinated with one dose of MenACWY should receive a second dose at the earliest opportunity, and continue to receive boosters at the appropriate interval. 60 Current booster recommendations are 3 years if <7 years at previous dose and at 5 years if !7 years at previous dose.…”

Section: Meningococcal Vaccination and Hivmentioning

confidence: 99%

Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative

Borrow

Caugant

Ceyhan

et al. 2017

Journal of Infection

View full text Add to dashboard Cite

“…However, HIV infection is increasingly recognized as a risk factor for meningococcal disease, and in June 2016, the Advisory Committee on Immunization Practices (ACIP) recommended routine quadrivalent meningococcal conjugate vaccine for all HIV-infected persons aged ≥2 months [6]. …”

mentioning

confidence: 99%

Increased Risk for Meningococcal Disease Among Men Who Have Sex With Men in the United States, 2012–2015

Folaranmi

Kretz

Kamiya

et al. 2017

Clinical Infectious Diseases

View full text Add to dashboard Cite

Background Several clusters of serogroup C meningococcal disease among men who have sex with men (MSM) have been reported in the United States in recent years. The epidemiology and risk of meningococcal disease among MSM is not well described. Methods All meningococcal disease cases among men aged 18–64 years reported to the National Notifiable Disease Surveillance System between January 2012 and June 2015 were reviewed. Characteristics of meningococcal disease cases among MSM and men not known to be MSM (non-MSM) were described. Annualized incidence rates among MSM and non-MSM were compared through calculation of the relative risk and 95% confidence intervals. Isolates from meningococcal disease cases among MSM were characterized using standard microbiological methods and whole-genome sequencing. Results Seventy-four cases of meningococcal disease were reported among MSM and 453 among non-MSM. Annualized incidence of meningococcal disease among MSM was 0.56 cases per 100 000 population, compared to 0.14 among non-MSM, for a relative risk of 4.0 (95% confidence interval [CI], 3.1–5.1). Among the 64 MSM with known status, 38 (59%) were infected with human immunodeficiency virus (HIV). HIV-infected MSM had 10.1 times (95% CI, 6.1–16.6) the risk of HIV-uninfected MSM. All isolates from cluster-associated cases were serogroup C sequence type 11. Conclusions MSM are at increased risk for meningococcal disease, although the incidence of disease remains low. HIV infection may be an important factor for this increased risk. Routine vaccination of HIV-infected persons with a quadrivalent meningococcal conjugate vaccine in accordance with Advisory Committee on Immunization Practices recommendations should be encouraged.

show abstract

Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016

Cited by 67 publications

References 11 publications

Meningococcal Disease in Patients With Human Immunodeficiency Virus Infection: A Review of Cases Reported Through Active Surveillance in the United States, 2000–2008

Meningococcal Disease in Patients With Human Immunodeficiency Virus Infection: A Review of Cases Reported Through Active Surveillance in the United States, 2000–2008

Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative

Increased Risk for Meningococcal Disease Among Men Who Have Sex With Men in the United States, 2012–2015

Contact Info

Product

Resources

About